[ Price : $8.95]
Representatives of innovator and generic drug companies disagree on the value of a 10-year drug exclusivity provision in the trade...[ Price : $8.95]
Public Citizens call for an end to the NIH-funded CLOVERS trial it says has serious regulatory and ethical lapses.[ Price : $8.95]
The 1st Circuit Appeals Court backs a federal district court decision that a suit seeking to use state laws to force prescription ...[ Price : $8.95]
FDA grants Reflection Biotechnologies an orphan drug designation for RBIO-101, an adeno-associated virus gene therapy product for ...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes one medical product company Kelley-Ross Compounding.[ Price : $8.95]
Federal Register notice: FDA determines that chikungunya virus disease, Lassa fever, rabies, and cryptococcal meningitis satisfy i...[ Price : $8.95]
Federal Register notice: FDA determines that Pneumocystis pneumonia does not meet statutory criteria for designation as a tropical...[ Price : $8.95]
FDA proposes to ban three bulk drug substances bumetanide, nicardipine hydrochloride, and vasopressin from its list of bulk drug...